BVMF/Q1UE34 (BVMF/Q1UE34)

Brazil Stock Exchange: BVMF/Q1UE34 · BRL

R$580

+0.00 (0.0%)· Recorded snapshot

Market cap	145.2B
Revenue (ttm)	61.3B
Net income (ttm)	5.8B
EPS (ttm)	R$26.8
P/E (trailing)	21.6x
P/E (forward)	21.0x
Dividend	R$5.79 (1.00%)
Volume	0
Beta	0.54

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 61.3B
Net income (ttm): 5.8B
EPS (ttm): R$26.8
P/E (trailing): 21.6x
P/E (forward): 21.0x
Market cap: 145.2B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E21

P25 n/aP50 n/aP75 n/a

Trailing P/E21.6

P25 n/aP50 n/aP75 n/a

ROE15.3

P25 n/aP50 n/aP75 n/a

ROIC10

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/Q1UE34 indicators

Market & fundamental data

Available fields

240

Groups with data

Currency

USD

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-10-22
Employees	57,000
Employees change	1,000
Employees growth	1.79%
Enterprise value	BRL 177.4B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-07-12
Fiscal year end	December
Founded	1967
Industry	Diagnostics & Research
Is primary listing	No
ISIN number	BRQ1UEBDR005
Last earnings date	2026-10-22
Last refreshed	2026-10-29
Market cap	BRL 145.2B
Next earnings date	2027-02-05
Price	BRL 579.60
Price currency	BRL
Sector	Healthcare
SIC code	8071
Stock price date	2026-09-22
Symbol	bvmf/Q1UE34
Website	https://www.questdiagnostics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	17.11x
Average P/E ratio (3Y)	20.34x
Average P/E ratio (5Y)	18.12x
Earnings yield	4.63%
EV/Earnings	30.45x
EV/EBIT	18.38x
EV/EBITDA	11.38x
EV/FCF	24.91x
EV/Sales	2.79x
FCF / EV yield	4.01%
FCF yield	4.91%
Forward P/E	21.03x
Graham number	294.81769
Graham upside	-49.13%
Lynch fair value	BRL 116.31
Lynch upside	-79.93%
P/(FCF - SBC) ratio	21.78x
P/(OCF - SBC) ratio	15.05x
P/B ratio	3.49x
P/E ratio	21.6x
P/FCF ratio	20.39x
P/OCF ratio	14.37x
P/S ratio	2.37x
Price/EBITDA ratio	11.92x
Sector forward P/E	11.05x
Sector P/E	41.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	14.92%
EBITDA margin	19.86%
Effective tax rate	22.47%
FCF margin	11.25%
Gross margin	33.18%
Operating margin	14.92%
Pretax margin	12.85%
Profit margin	9.53%
Profit per employee	BRL 113,153
Profitable quarters	62
Profitable years	26
Revenue per employee	BRL 1.2M
ROA	6.61%
ROA (5Y)	7.22%
ROCE	11.48%
ROE	15.32%
ROE (5Y)	18.06%
ROIC	10.03%
ROIC (5Y)	11.34%
SBC / revenue	0.74%
Tax / revenue	2.89%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	17.89%
EPS growth (Q)	28.7%
EPS growth (QoQ)	-2.11%
EPS growth 10Y	7.86%
EPS growth 3Y	14.62%
EPS growth 5Y	-9.61%
EPS growth quarters	9
EPS growth years	2
FCF growth	-1.29%
FCF growth (Q)	6.21%
FCF growth (QoQ)	-3.05%
FCF growth 3Y	32.14%
FCF growth 5Y	-5.98%
Gross profit growth	8.21%
Gross profit growth (Q)	9.57%
Gross profit growth 3Y	8.17%
Gross profit growth 5Y	-2.71%
Net income growth	16.51%
Net income growth (Q)	27.35%
Net income growth (QoQ)	-2.82%
Net income growth 3Y	14.02%
Net income growth 5Y	-12.35%
Net income growth quarters	9
Net income growth years	2
OCF growth	3.5%
OCF growth (Q)	8.53%
OCF growth (QoQ)	2.35%
OCF growth 10Y	6.52%
OCF growth 3Y	21.83%
OCF growth 5Y	-3.18%
Operating income growth	12.84%
Operating income growth (Q)	16.91%
Operating income growth 3Y	12.05%
Operating income growth 5Y	-8.36%
Revenue growth	9.13%
Revenue growth (Q)	9.98%
Revenue growth (QoQ)	1.77%
Revenue growth 10Y	4.67%
Revenue growth 3Y	8.4%
Revenue growth 5Y	1.4%
Revenue growth quarters	11
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -3B
Depreciation and amortization	BRL 3.1B
EBIT	BRL 9.2B
EBITDA	BRL 12.2B
EPS	BRL 26.83
Financing cash flow	BRL -4.9B
Free cash flow	BRL 7.1B
Free cash flow minus SBC	BRL 6.7B
Gross profit	BRL 20.4B
Income taxes	BRL 1.8B
Investing cash flow	BRL -3.3B
Net borrowing	BRL -58.8M
Net cash flow	BRL 1.9B
Net income	BRL 5.8B
Operating cash flow minus SBC	BRL 9.7B
Operating income	BRL 9.2B
Revenue	BRL 61.3B
Stock-based compensation	BRL 455.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.43
Book value per share	BRL 359.39
Debt / EBITDA	2.23
Debt / equity	0.8
Debt / FCF	4.65
Goodwill	BRL 48.7B
Interest coverage	6.62
Long-term assets	BRL 72.5B
Long-term liabilities	BRL 37.8B
Net cash (debt)	BRL -29B
Net cash / market cap	-19.98%
Net debt / EBITDA	2.38
Net debt / equity	0.7
Net debt / FCF	4.07
Piotroski F-Score	6
Property, plant and equipment	BRL 15.7B
Shareholders' equity	BRL 41.6B
Tangible book value	BRL -16.1B
Tangible book value per share	BRL -146.64
Total assets	BRL 89.2B
Total cash	BRL 4.1B
Total debt	BRL 33.1B
Total liabilities	BRL 47.6B
WACC	6.48%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.71
Current assets	BRL 16.7B
Current liabilities	BRL 9.8B
Current ratio	1.7
Inventory turnover	39.17
Net working capital	BRL 3.5B
Quick ratio	1.37
Working capital	BRL 6.6B
Working capital turnover	78.84

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.32%
Dividend growth	-3.71%
Dividend growth (3Y)	7.46%
Dividend growth (5Y)	5.45%
Dividend growth years	5
Dividend payment date	2026-10-27
Dividend payment years	7
Dividend payout frequency	Quarterly
Dividend per share	BRL 5.79
Dividend yield	1%
Ex-dividend date	2026-10-05
Last dividend	BRL 1.46
Payout ratio	32.68%
Shareholder yield	2.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 380.68
1D price change	0%
1M price change	-5.57%
1M total return	-5.33%
1W price change	-5.57%
1W total return	-5.33%
1Y price change	20.45%
1Y return CAGR	22.17%
1Y total return	22.15%
20-day SMA	BRL 490.71
200-day SMA	BRL 365.22
3M price change	15.33%
3M total return	16.27%
50-day SMA	BRL 406.07
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 613.80
52-week high date	2026-08-13
52-week low	BRL 478.31
52-week low date	2026-02-23
5Y price change	41.3%
5Y return CAGR	8.63%
5Y total return	51.28%
6M price change	9.49%
6M total return	10.37%
All-time high	BRL 613.80
All-time high date	2026-08-13
All-time low	BRL 189.00
All-time low date	2020-03-20
Average true range (ATR)	BRL 21.73
Average volume	12.3
Beta (5Y)	0.54
Change from 52-week high	-5.57%
Change from 52-week low	21.18%
Change from all-time high	-5.57%
Change from all-time low	206.67%
Change from open	0%
Day's gap	0%
High price	BRL 579.60
Low price	BRL 579.60
Monthly RSI	66.78
Open price	BRL 579.60
Previous close	BRL 579.60
Price vs 150-day SMA	52.26%
Price vs 20-day SMA	18.12%
Price vs 200-day SMA	58.7%
Price vs 50-day SMA	42.73%
Relative volume	0.16
RSI	68.77
Sharpe ratio	1.41
Sortino ratio	2.38
Volume	0
Weekly RSI	72.87

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	109.5M
Shares change (QoQ)	0%
Shares change (YoY)	-1.32%
Shares held by insiders	0.36%
Shares held by institutions	97.1%
Short ratio	3.6 days

Deeper analysis on BVMF/Q1UE34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/Q1UE34 report

Is a complete BVMF/Q1UE34 research report available?

No complete published report is available for bvmf/Q1UE34 (BVMF/Q1UE34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/Q1UE34 (BVMF/Q1UE34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/Q1UE34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/Q1UE34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/Q1UE34

Frequently asked questions